Cellectis S.A.
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Business sectors
- research and development in biotechnology [1]
- Company / filing name
- Cellectis S.A. [2]
- Headquarters location
- France [1]
- Founded
- 1999 [1]
- Legal form
- public limited company with a board of directors (n.o.s.) [1]
- Founders
- André Choulika [1]
- Official website
- www.cellectis.com ↗ [1]
- ISIN (reported securities)
- FR0010425595 [1]
- CIK
- 1627281 [2]
- Country in background record
- France [1]
- Symbols / exchanges
- CLLS (Nasdaq) [2]
Company positioning and business
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina. [3]
Background text: Wikipedia contributors, Cellectis. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
Listed securities: CLLS (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [2]
History and key events
Founding / inception date recorded in Wikidata. [1]
Financial results and regulatory disclosures
No individual financial documents have been indexed yet. Open the source to consult company disclosures. [2]
Related entities and concepts
Frequently asked questions
When was Cellectis S.A. founded?
Founded: 1999. The linked source provides the background record. [1]
Where is the headquarters of Cellectis S.A.?
Headquarters location: France. The linked source provides the background record. [1]
Which business sectors are recorded for Cellectis S.A.?
Business sectors: research and development in biotechnology. The linked source provides the background record. [1]
Sources and review dates
- Wikidata — company background record (CC0) ↗
- Company identity and profile data ↗
- Wikipedia contributors — Cellectis (CC BY-SA 4.0) ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.